SCHEMBL1899064

SCHEMBL1899064

CCCCNC=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492779 0.92
SCHEMBL19527248 0.89 EPHX1 (0.61)
SCHEMBL20036343 0.89 EPHX1 (0.61)
SCHEMBL29257633 0.89 EPHX1 (0.61)
SCHEMBL29257635 0.89 EPHX1 (0.61)
SCHEMBL7041700 0.89 EPHX1 (0.61)
SCHEMBL1895673 0.81
SCHEMBL18965744 0.75 ADH1B (0.60)
SCHEMBL28366675 0.75 ADH1B (0.60)
SCHEMBL22755592 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024173710-A1 AMMONIUM CATIONS IN PEROVSKITE SOLAR CELLS AND USES THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2024-08-22 WO disclosed
EP-2970176-B1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2023-10-25 EP disclosed
EP-3507275-B1 CXCR3 RECEPTOR AGONISTS RECEPTOS LLC (US) 2023-04-26 EP disclosed
WO-2021257544-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2021-12-23 WO disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed
EP-3747883-A1 MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION Medshine Discovery Inc. (CN) 2020-12-09 EP disclosed
WO-2019244082-A2 ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS NOVARTIS AG (CH) 2019-12-26 WO disclosed
WO-2019049174-A1 SOLID STATE FORMS OF 5-CHLORO-6-[(2-IMINOPYRROLIDIN-1-YL)METHYL]PYRIMIDINE-2,4-(1H,3H)-DIONE HYDROCHLORIDE AND THEIR PROCESSES FOR THE PREPARATION THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2019-03-14 WO disclosed
US-9694099-B2 Ophthalmic and contact lens solutions using choline FXS VENTURES, LLC (US) 2017-07-04 US disclosed
US-20160128325-A1 OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE FXS VENTURES, LLC 2016-05-12 US disclosed
WO-2006076243-A1 PROCESSES FOR PREPARING 4-(PHENOXY-5-METHYL-PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLIC ACID DERIVATIVES AND RELATED COMPOUNDS ARENA PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed
WO-2006076455-A2 PROCESSES FOR PREPARING PYRAZOLO[3,4-D]PYRIMIDINE ETHERS ARENA PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed
US-20060154940-A1 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers ARENA PHARMACEUTICALS, INC. 2006-07-13 US disclosed
US-20060155129-A1 Processes for preparing aromatic ethers ARENA PHARMACEUTICALS, INC. 2006-07-13 US disclosed
EP-1644357-A1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2006-04-12 EP disclosed
WO-2005007647-A9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2005-04-07 WO disclosed
US-20050070562-A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. 2005-03-31 US disclosed
WO-2005007647-A1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2005-01-27 WO disclosed
US-5264448-A Thioamides, oxazole ring, insecticides, miticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-11-23 US disclosed
EP-0394043-A1 An amide compound and its production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-10-24 EP disclosed